HL151 clinical trials
Also written HL151.
How each study uses HL151 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Development codes
- HL151
- 4
Studies by the year they started
4 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2016 | 2 |
| 2017 | 2 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 4 · Other 0
Studies
Open first, then newest update. How each study uses HL151 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 4
- To Evaluate the Efficacy and Safety of HL151 Versus Placebo in Perennial Allergic Rhinitis PatientsCompletedPhase 3Hanlim Pharm. Co., Ltd.NCT03655210Written as HL151
- Evaluate the Efficacy and Safety of HL151 Versus Talion Tab. in Pruritus CutaneusCompletedPhase 3Hanlim Pharm. Co., Ltd.NCT03317301Written as HL151
- Repeated Dosing Clinical Trial of HL151CompletedPhase 1Hanlim Pharm. Co., Ltd.NCT02686294Written as HL151
- Single Dosing Clinical Trial of HL151CompletedPhase 1Hanlim Pharm. Co., Ltd.NCT02682745Written as HL151